Calliditas Therapeutics AB
Position | Amount | ||||||||
---|---|---|---|---|---|---|---|---|---|
2022-12-22 | Calliditas Therapeutics AB | Frank Bringstrup | Other member of the company's administrative, management or supervisory body | Disposal | 5 500 | 96,8 | SEK | 532 400 | 2022-12-18 |
2022-12-22 | Calliditas Therapeutics AB | Frank Bringstrup | Other member of the company's administrative, management or supervisory body | Exercise increase | 7 500 | 74,5 | SEK | 558 750 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | RENÉE AGUIAR LUCANDER | Chief Executive Officer (CEO)/Managing Directory | Exercise decrease | 195 000 | 0 | SEK | 0 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | RENÉE AGUIAR LUCANDER | Chief Executive Officer (CEO)/Managing Directory | Disposal | 145 000 | 92,75 | SEK | 13 448 750 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | RENÉE AGUIAR LUCANDER | Chief Executive Officer (CEO)/Managing Directory | Exercise increase | 195 000 | 74,5 | SEK | 14 527 500 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | RENÉE AGUIAR LUCANDER | Chief Executive Officer (CEO)/Managing Directory | Loan received | 145 000 | 0 | SEK | 0 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Fredrik Johansson | Chief Financial Officer (CFO) | Exercise decrease | 50 000 | 0 | SEK | 0 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Fredrik Johansson | Chief Financial Officer (CFO) | Loan received | 45 000 | 0 | SEK | 0 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Fredrik Johansson | Chief Financial Officer (CFO) | Exercise increase | 50 000 | 74,5 | SEK | 3 725 000 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Fredrik Johansson | Chief Financial Officer (CFO) | Disposal | 45 000 | 92,75 | SEK | 4 173 750 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Katayoun Fatemeh Welin-Berger | Other member of the company's administrative, management or supervisory body | Loan received | 65 000 | 0 | SEK | 0 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Katayoun Fatemeh Welin-Berger | Other member of the company's administrative, management or supervisory body | Exercise increase | 65 000 | 74,5 | SEK | 4 842 500 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Katayoun Fatemeh Welin-Berger | Other member of the company's administrative, management or supervisory body | Exercise decrease | 65 000 | 0 | SEK | 0 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Katayoun Fatemeh Welin-Berger | Other member of the company's administrative, management or supervisory body | Disposal | 65 000 | 92,75 | SEK | 6 028 750 | 2022-12-19 |
2022-12-23 | Calliditas Therapeutics AB | Andrew Udell | Other member of the company's administrative, management or supervisory body | Disposal | 20 000 | 16,85 | SEK | 337 000 | 2022-12-19 |
2022-12-30 | Calliditas Therapeutics AB | Katayoun Fatemeh Welin-Berger | Other member of the company's administrative, management or supervisory body | Return of loan decrease | 65 000 | 0 | SEK | 0 | 2022-12-27 |
2022-12-30 | Calliditas Therapeutics AB | Fredrik Johansson | Chief Financial Officer (CFO) | Return of loan decrease | 45 000 | 0 | SEK | 0 | 2022-12-27 |
2022-12-30 | Calliditas Therapeutics AB | RENÉE AGUIAR LUCANDER | Chief Executive Officer (CEO)/Managing Directory | Return of loan decrease | 145 000 | 0 | SEK | 0 | 2022-12-27 |
2023-07-04 | Calliditas Therapeutics AB | Elmar Schnee | Chairman of the Board of Directors | Acquisition | 13 000 | 84,063 | SEK | 1 092 824,525 | 2023-07-02 |
2024-07-03 | Calliditas Therapeutics AB | Richard Philipson | Other member of the company's administrative, management or supervisory body | Acquisition | 50 885 | 0 | SEK | 0 | 2024-06-30 |